GeneDx (WGS) Insider Trading
Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for GeneDx.
Bought (12 mo)
$106,601,465
Sold (12 mo)
$21,810,078
Insiders Buying (12 mo)
6
Insiders Selling (12 mo)
4
Form 4 Filings (All Time)
389
Most Recent Purchase
June 8, 2026
Casdin Partners Master Fund, L.P.
Director
$11,109,565
Most Recent Sale
September 18, 2026
Katherine Stueland
CEO
$1,025,013
Buys (90d)
0
Sells (90d)
5
Recent Insider Transactions
| Filed | Insider | Role | Type | Value | % Change |
|---|---|---|---|---|---|
| 2026-09-18 | Fuchs Thomas | Director | Exercise | — | — |
| 2026-09-18 | Stueland Katherine | CEO | Sell | $1,025,013 | +7.0% |
| 2026-09-18 | Feeley Kevin | CFO | Sell | $363,892 | +7.7% |
| 2026-09-11 | Feeley Kevin | CFO | Sell | $108,220 | +2.8% |
| 2026-09-11 | Stueland Katherine | CEO | Sell | $310,932 | +2.6% |
| 2026-09-03 | Feeley Kevin | CFO | Sell | $31,188 | +0.9% |
Sign up free to view more insider trades.